FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993619587> ?p ?o ?g. }

• W1993619587 endingPage "264" @default.
• W1993619587 startingPage "256" @default.
• W1993619587 abstract "Cyclophosphamide (CYC) has proven beneficial in preserving renal function in patients with lupus with diffuse proliferative glomerulonephritis (DPGN). However, the optimal route of CYC administration is unknown because direct comparative studies are unavailable. In this open study, we compared the renal outcome of two historical cohorts of patients with diffuse proliferative lupus nephritis (World Health Organization classes IVa and IVb) treated with either intravenous (IV) pulse CYC (group A; n [equals] 22) or sequential oral CYC followed by azathioprine (AZA; group B; n [equals] 21) and followed up prospectively. Both groups of patients had similar clinical, biochemical, and renal parameters at baseline. At 24 months posttreatment, significant improvements in proteinuria, creatinine clearance, serum albumin level, and lupus serological results were evident in both groups. Compared with patients in group A, patients in group B had more complete or partial remission (90% versus 73%) and less risk for treatment failure (5% versus 14%), renal flares (5% versus 14%), and doubling of creatinine levels (5% versus 9%), but the difference was not statistically significant. However, patients treated with oral immunosuppression had an insignificant increase in rates of herpes zoster infection (19% versus 9%) and menstrual disturbance (50% versus 29%). We conclude that sequential oral immunosuppression with CYC and AZA tended to have better efficacy than IV pulse CYC in the treatment of lupus DPGN but was associated with more toxicities. Additional randomized trials involving a larger cohort of patients with a longer period of observation are necessary. [copy ] 2001 by the National Kidney Foundation, Inc." @default.
• W1993619587 created "2016-06-24" @default.
• W1993619587 creator A5004488408 @default.
• W1993619587 creator A5008203320 @default.
• W1993619587 creator A5033947419 @default.
• W1993619587 creator A5036448434 @default.
• W1993619587 creator A5052148741 @default.
• W1993619587 creator A5052193047 @default.
• W1993619587 creator A5072181664 @default.
• W1993619587 creator A5084912195 @default.
• W1993619587 date "2001-08-01" @default.
• W1993619587 modified "2023-09-24" @default.
• W1993619587 title "Treatment of diffuse proliferative lupus glomerulonephritis: A comparison of two cyclophosphamide-containing regimens" @default.
• W1993619587 cites W11221851 @default.
• W1993619587 cites W1935701701 @default.
• W1993619587 cites W1965062568 @default.
• W1993619587 cites W1991478374 @default.
• W1993619587 cites W1998540145 @default.
• W1993619587 cites W2006122820 @default.
• W1993619587 cites W2007198494 @default.
• W1993619587 cites W2009145517 @default.
• W1993619587 cites W2014596999 @default.
• W1993619587 cites W2021736794 @default.
• W1993619587 cites W2029308711 @default.
• W1993619587 cites W2048350130 @default.
• W1993619587 cites W2053582855 @default.
• W1993619587 cites W2069648600 @default.
• W1993619587 cites W2073418778 @default.
• W1993619587 cites W2133264060 @default.
• W1993619587 cites W2135212798 @default.
• W1993619587 cites W2143660127 @default.
• W1993619587 cites W2166144559 @default.
• W1993619587 cites W224586676 @default.
• W1993619587 cites W2325870812 @default.
• W1993619587 cites W2336696641 @default.
• W1993619587 cites W2339857727 @default.
• W1993619587 cites W2403260371 @default.
• W1993619587 cites W2412628206 @default.
• W1993619587 cites W2415241547 @default.
• W1993619587 cites W2417241914 @default.
• W1993619587 cites W2418211114 @default.
• W1993619587 cites W36275675 @default.
• W1993619587 doi "https://doi.org/10.1053/ajkd.2001.26084" @default.
• W1993619587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11479150" @default.
• W1993619587 hasPublicationYear "2001" @default.
• W1993619587 type Work @default.
• W1993619587 sameAs 1993619587 @default.
• W1993619587 citedByCount "97" @default.
• W1993619587 countsByYear W19936195872012 @default.
• W1993619587 countsByYear W19936195872013 @default.
• W1993619587 countsByYear W19936195872014 @default.
• W1993619587 countsByYear W19936195872015 @default.
• W1993619587 countsByYear W19936195872016 @default.
• W1993619587 countsByYear W19936195872017 @default.
• W1993619587 countsByYear W19936195872018 @default.
• W1993619587 countsByYear W19936195872019 @default.
• W1993619587 countsByYear W19936195872020 @default.
• W1993619587 countsByYear W19936195872021 @default.
• W1993619587 crossrefType "journal-article" @default.
• W1993619587 hasAuthorship W1993619587A5004488408 @default.
• W1993619587 hasAuthorship W1993619587A5008203320 @default.
• W1993619587 hasAuthorship W1993619587A5033947419 @default.
• W1993619587 hasAuthorship W1993619587A5036448434 @default.
• W1993619587 hasAuthorship W1993619587A5052148741 @default.
• W1993619587 hasAuthorship W1993619587A5052193047 @default.
• W1993619587 hasAuthorship W1993619587A5072181664 @default.
• W1993619587 hasAuthorship W1993619587A5084912195 @default.
• W1993619587 hasConcept C126189478 @default.
• W1993619587 hasConcept C126322002 @default.
• W1993619587 hasConcept C159641895 @default.
• W1993619587 hasConcept C159654299 @default.
• W1993619587 hasConcept C203014093 @default.
• W1993619587 hasConcept C2775915377 @default.
• W1993619587 hasConcept C2776694085 @default.
• W1993619587 hasConcept C2776755627 @default.
• W1993619587 hasConcept C2776760755 @default.
• W1993619587 hasConcept C2776912625 @default.
• W1993619587 hasConcept C2778720950 @default.
• W1993619587 hasConcept C2779134260 @default.
• W1993619587 hasConcept C2779561371 @default.
• W1993619587 hasConcept C2779912601 @default.
• W1993619587 hasConcept C2780091579 @default.
• W1993619587 hasConcept C2780252810 @default.
• W1993619587 hasConcept C2780306776 @default.
• W1993619587 hasConcept C2780368995 @default.
• W1993619587 hasConcept C71924100 @default.
• W1993619587 hasConcept C90924648 @default.
• W1993619587 hasConceptScore W1993619587C126189478 @default.
• W1993619587 hasConceptScore W1993619587C126322002 @default.
• W1993619587 hasConceptScore W1993619587C159641895 @default.
• W1993619587 hasConceptScore W1993619587C159654299 @default.
• W1993619587 hasConceptScore W1993619587C203014093 @default.
• W1993619587 hasConceptScore W1993619587C2775915377 @default.
• W1993619587 hasConceptScore W1993619587C2776694085 @default.
• W1993619587 hasConceptScore W1993619587C2776755627 @default.
• W1993619587 hasConceptScore W1993619587C2776760755 @default.
• W1993619587 hasConceptScore W1993619587C2776912625 @default.
• W1993619587 hasConceptScore W1993619587C2778720950 @default.

• next